Late safety and efficacy of a Zotarolimus-Eluting stent compared with a Paclitaxel-Eluting stent in patients with de novo coronary lesions : Three-year follow-up from the ENDEAVOR IV Trial (abstract)

• LEON MB

収録刊行物

• Am J Cardiol

  Am J Cardiol 104 150D-, 2009

詳細情報

• CRID: 1571980075955151616
• NII論文ID: 10026972649
• データソース種別:
  • CiNii Articles